FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801786639> ?p ?o ?g. }

• W2801786639 endingPage "201" @default.
• W2801786639 startingPage "195" @default.
• W2801786639 abstract "The necessity for adjuvant chemotherapy (ACT) in locally advanced rectal cancer (LARC) patients who achieve pathological complete response (pCR) after pre-operative chemoradiotherapy (CRT) is still not identified. We aimed to investigate the therapeutic value of ACT in these patients.Clinical data were retrospectively collected from 105 consecutive LARC patients who achieved pCR after pre-operative CRT and underwent radical tumor resection between December 2008 and April 2014 in a comprehensive cancer center. Perioperative chemotherapy (CT) was administered by combining oxaliplatin with capecitabine (XELOX regimen). Disease-free survival (DFS) and overall survival (OS) rates of patients with or without ACT were compared.Eighty-three (79.0%) patients received ACT and 22 (21.0%) did not. With a median follow-up of 49 months, the ACT group had a significantly higher 3-year DFS rate (92.8 vs 86.4%, p = 0.029) and 3-year OS rate (95.1 vs 86.1%, p = 0.026) than the non-ACT group. In multivariable analyses, the presence of ACT was an independent prognostic factor for DFS (hazard ratio [HR]: 0.271; 95% confidence interval (CI): 0.080-0.916; p = 0.036) but not for OS. This benefit was more obvious in patients younger than 60 years via subgroup analysis (adjusted HR: 0.106; 95% CI: 0.019-0.606; p = 0.012).Oxaliplatin-containing ACT may confer survival benefits to patients with pCR, particularly younger patients. However, the routine use of ACT in patients with pCR needs further validation." @default.
• W2801786639 created "2018-05-17" @default.
• W2801786639 creator A5002052225 @default.
• W2801786639 creator A5017055867 @default.
• W2801786639 creator A5020847968 @default.
• W2801786639 creator A5027887655 @default.
• W2801786639 creator A5054760799 @default.
• W2801786639 creator A5061191217 @default.
• W2801786639 creator A5081715749 @default.
• W2801786639 creator A5085712538 @default.
• W2801786639 creator A5088086867 @default.
• W2801786639 date "2018-04-27" @default.
• W2801786639 modified "2023-10-16" @default.
• W2801786639 title "Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy" @default.
• W2801786639 cites W1944391634 @default.
• W2801786639 cites W1958813734 @default.
• W2801786639 cites W1977468182 @default.
• W2801786639 cites W2003589572 @default.
• W2801786639 cites W2008457692 @default.
• W2801786639 cites W2027176779 @default.
• W2801786639 cites W2029983428 @default.
• W2801786639 cites W2056835261 @default.
• W2801786639 cites W2097656606 @default.
• W2801786639 cites W2100258195 @default.
• W2801786639 cites W2113818241 @default.
• W2801786639 cites W2118983280 @default.
• W2801786639 cites W2124886112 @default.
• W2801786639 cites W2125452425 @default.
• W2801786639 cites W2133114579 @default.
• W2801786639 cites W2134268158 @default.
• W2801786639 cites W2138446143 @default.
• W2801786639 cites W2140728431 @default.
• W2801786639 cites W2143655828 @default.
• W2801786639 cites W2144717403 @default.
• W2801786639 cites W2165147735 @default.
• W2801786639 cites W2168680994 @default.
• W2801786639 cites W2214826415 @default.
• W2801786639 cites W2219257584 @default.
• W2801786639 cites W2340331865 @default.
• W2801786639 cites W2554181781 @default.
• W2801786639 cites W2560171039 @default.
• W2801786639 doi "https://doi.org/10.1093/gastro/goy009" @default.
• W2801786639 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6101492" @default.
• W2801786639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30151204" @default.
• W2801786639 hasPublicationYear "2018" @default.
• W2801786639 type Work @default.
• W2801786639 sameAs 2801786639 @default.
• W2801786639 citedByCount "5" @default.
• W2801786639 countsByYear W28017866392020 @default.
• W2801786639 countsByYear W28017866392021 @default.
• W2801786639 countsByYear W28017866392023 @default.
• W2801786639 crossrefType "journal-article" @default.
• W2801786639 hasAuthorship W2801786639A5002052225 @default.
• W2801786639 hasAuthorship W2801786639A5017055867 @default.
• W2801786639 hasAuthorship W2801786639A5020847968 @default.
• W2801786639 hasAuthorship W2801786639A5027887655 @default.
• W2801786639 hasAuthorship W2801786639A5054760799 @default.
• W2801786639 hasAuthorship W2801786639A5061191217 @default.
• W2801786639 hasAuthorship W2801786639A5081715749 @default.
• W2801786639 hasAuthorship W2801786639A5085712538 @default.
• W2801786639 hasAuthorship W2801786639A5088086867 @default.
• W2801786639 hasBestOaLocation W28017866391 @default.
• W2801786639 hasConcept C121608353 @default.
• W2801786639 hasConcept C126322002 @default.
• W2801786639 hasConcept C141071460 @default.
• W2801786639 hasConcept C143998085 @default.
• W2801786639 hasConcept C207103383 @default.
• W2801786639 hasConcept C2776694085 @default.
• W2801786639 hasConcept C2777909004 @default.
• W2801786639 hasConcept C2778424827 @default.
• W2801786639 hasConcept C2780962732 @default.
• W2801786639 hasConcept C2781413609 @default.
• W2801786639 hasConcept C31174226 @default.
• W2801786639 hasConcept C44249647 @default.
• W2801786639 hasConcept C526805850 @default.
• W2801786639 hasConcept C71924100 @default.
• W2801786639 hasConceptScore W2801786639C121608353 @default.
• W2801786639 hasConceptScore W2801786639C126322002 @default.
• W2801786639 hasConceptScore W2801786639C141071460 @default.
• W2801786639 hasConceptScore W2801786639C143998085 @default.
• W2801786639 hasConceptScore W2801786639C207103383 @default.
• W2801786639 hasConceptScore W2801786639C2776694085 @default.
• W2801786639 hasConceptScore W2801786639C2777909004 @default.
• W2801786639 hasConceptScore W2801786639C2778424827 @default.
• W2801786639 hasConceptScore W2801786639C2780962732 @default.
• W2801786639 hasConceptScore W2801786639C2781413609 @default.
• W2801786639 hasConceptScore W2801786639C31174226 @default.
• W2801786639 hasConceptScore W2801786639C44249647 @default.
• W2801786639 hasConceptScore W2801786639C526805850 @default.
• W2801786639 hasConceptScore W2801786639C71924100 @default.
• W2801786639 hasIssue "3" @default.
• W2801786639 hasLocation W28017866391 @default.
• W2801786639 hasLocation W28017866392 @default.
• W2801786639 hasLocation W28017866393 @default.
• W2801786639 hasLocation W28017866394 @default.
• W2801786639 hasOpenAccess W2801786639 @default.
• W2801786639 hasPrimaryLocation W28017866391 @default.
• W2801786639 hasRelatedWork W1953161284 @default.

• next